Exclusive Interview: Lexaria CEO Discusses Progress & Plans at O’Cannabiz 2018


Ryan Allway

January 9th, 2019

News, Top Story


The O’Cannabiz Conference and Expo in Vancouver, Canada last month featured hundreds of cannabis companies from around the world this year—and CFN Media was there to film exclusive interviews with many of the leaders in the space.

Lexaria Biosciences Inc. (CSE: LXX) (OTCQX: LXRP), developer of drug delivery technologies for bioactive compounds, is one of the oldest companies in the cannabis industry. After developing DehydraTECH for the pharmaceutical industry, the company pivoted into the cannabis space about five years ago. The patented technology is now an integral part of numerous commercial products across the U.S. and Canada.

CFN Media caught up with CEO Chris Bunka at the conference to discuss the company’s progress over the past year and plans moving forward.

In this article, we will take a closer look at how Lexaria is helping cannabis companies, as well as explore some other opportunities for 2019 and beyond.

Lexaria Improves Cannabis Products

Lexaria’s patented drug delivery technology is designed to make cannabis products taste better, smell better, and quickly enter the bloodstream. Unlike many other drug delivery technologies, DehydraTECH uses only GRAS (generally recognized as safe) ingredients—eliminating the need for any extra labeling requirements—and costs less than a penny per serving to integrate in commercial cannabis products.

DehydraTECH masks the bitter taste and smell of cannabis by encapsulating cannabinoid compounds in a lipid molecule. In addition to these benefits, the approach also improves bioavailability by protecting the cannabinoid compounds from stomach and first-pass liver metabolism. Research has shown that the technology improves bioavailability by five to ten times, while producing a much more rapid onset than conventional edibles.

The company has already commercialized the platform in the U.S. and Canada. For example, Nuka Enterprises LLC licensed the DehydraTECH platform for its 1906 brand of cannabis chocolates and other edibles for the past two years. Since then, the company has grown from a small startup to Colorado’s third largest cannabis chocolate brand with products in over 150 locations—and it’s considered one of the most innovative brands in the space.

Multiple Potential Markets for Licensing

Lexaria’s initial focus has been on the cannabis industry given the significant challenges that edible-makers have faced with masking taste and smell. While the market has provided significant early revenue, the biggest opportunities are in much larger markets measured in the billions of dollars per year in revenue. In fact, the combined end markets for the innovative technology could be measured in the trillions of dollars.

The most near-term opportunities lies in the nicotine market, where it could be used in smoking cessation products. More than half of smokers have indicated that they would like to quit smoking, but nicotine’s addictiveness makes it difficult. Nicotine gum can be effective, but it’s not the best delivery method. DehydraTECH could lead to numerous nicotine products, as well as much more rapid onset—more like that of smoking than chewing.

Management also plans to develop inroads into the traditional pharmaceutical industry—including pain medications—and the wellness industry—such as vitamins. With greater bioavailability and faster onset, these are prime markets where DehydraTECH could make a meaningful difference at a fraction of the cost. These markets are also worth significantly more than the cannabis industry in terms of size.

Looking Ahead

Lexaria Biosciences Inc. (CSE: LXX) (OTCQX: LXRP) represents a compelling investment opportunity within the cannabis industry. With over 50 patents pending and ten patents granted, the company is rapidly expanding its addressable market from cannabis to pharmaceuticals, wellness, and other areas. Investors may want to keep a close eye on the company as it continues to roll out in these areas.

For more information, visit the company’s website or download their investor presentation.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://www.cannabisfn.com/legal-disclaimer/

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Learn How Your Company can Be Covered on CFN Media

Learn More About the CFN Media Sponsored Content Program

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © TDM Financial LLC · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading